ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

STUDY TO KNOW OUTCOMES OF MYOCARDIAL INFARCTION IN DIABETIC AND NON-DIABETIC PATIENTS TREATED WITH STREPTOKINASE HAVING ST SEGMENT ELEVATION

Dr Syed Zuhair, Dr Marriam Nadeem, Dr Mariam Siddique

Objective: To compare the efficacy of streptokinase in MI with diabetic and non-diabetic patients with ST-segment elevation. Study design: A randomized clinical trial. Duration: For one Year Duration, from August 2018 to July 2019. Materials and methods: The myocardial infarction Patients with ST segment elevation were taken from the Department of Cardiology of Services Hospital Lahore. Results: The initial characteristics of patients with non-diabetic and diabetic myocardial infarction, ie, the mean age of the patients in both groups were similar and 49.43 ± 4.27 in diabetics, and 46.74 ± 3.12 in the group. 82.5% of non-diabetic patients were male and 74.5% were diabetic. A comparison of streptokinase activity was recorded in the diabetic and non-diabetic patients in ST segment elevation, 85% in patients who were non-diabetic and only 30% in patients who were diabetic. P value was calculated as 0.00. Conclusion: In the light of current results, it can be concluded that thrombolytic therapy is more effective in diabetic patients than in patients with STEMI diabetes; However, more attention should be paid to diabetic individuals before thrombolytic therapy is administered.

FULL TEXT